Evaluate the proportion of seronegative auto-immune hepatitis and a possible relationship with the severity of the disease. Criteria of severity will be defined by corticodependance, corticoresistance and a severe form of the disease at diagnosis (cirrhosis or fulminant hepatitis). In case of predominant seronegative forms, other auto-antibodies related to this auto-immue hepatitis will be searched.
Evaluate the proportion of seronegative auto-immune hepatitis and a possible relationship with the severity of the disease. Criteria of severity will be defined by corticodependance, corticoresistance and a severe form of the disease at diagnosis (cirrhosis or fulminant hepatitis). In case of predominant seronegative forms, other auto-antibodies related to this auto-immue hepatitis will be searched. Patients from the Guadeloupean constitutive center of rare diseases (CCRD Filfoie) and from the Saint-Antoine hospital will be retrospectively analyzed, and new patients will be prospectively followed.
Study Type
OBSERVATIONAL
Enrollment
100
For the study, a blood sample will be collected from the patient in order to do build up a serological library which will allow the search for rare autoAb whose interest has been demonstrated as prognostic factors of the disease.
Hospital of Saint-Antoine
Paris, France, France
NOT_YET_RECRUITINGCHU de Pointe-à Pitre
Pointe à Pitre, Guadeloupe, France
RECRUITINGhistological rereading of seronegative AIH
Percentage comparisons will be made by a chi-2 test or a Fischer test.
Time frame: Baseline
assessment of the severity of the disease
\- Number of corticosteroid HAI defined by the maintenance of corticosteroid therapy\> 20mg / d beyond 6 months of treatment - Number of corticosteroid-resistant AIH. Percentage comparisons will be made by a chi-2 test or a Fischer test.
Time frame: 6 months, 12 months
Constitution of a serotheque in order to search for other autoAb described as correlated to the severity of the AIH.
Constitution of a serotheque in order to search for other autoAb described as correlated to the severity of the AIH.
Time frame: At inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.